Recent media items include:
- In Bloomberg Law, Tom Bulleit Discusses New “Stark” and Anti-Kickback Rules for Value-Based Arrangements (November 25, 2020)
- In Law360, Health Care Attorneys Examine State Drug Pricing Reforms (November 25, 2020)
- In Law360, IP Litigators Discuss Federal Circuit Ruling on Patent Venue Statute and Hatch-Waxman Act (November 18, 2020)
- Ropes & Gray Successfully Defends Another GREE Patent from a PTAB Petition (November 13, 2020)
- In Law360, Attorneys Analyze Two HHS Opinions That Support Broad Immunity from COVID-19 Liability (November 10, 2020)
- In Law360, Attorneys Examine Change in FDA's Review Priorities for COVID-19 Lab-Developed Tests (October 22, 2020)
- In Bloomberg Law, Greg Levine Evaluates FDA Plans for Permanent COVID-19 Test Authorization (October 20, 2020)
- In Food and Drug Law Institute Update Magazine, Attorneys Track Drug and Device Enforcement During COVID-19 (October 6, 2020)
- In Law360, Health Care Attorneys Address President Trump’s Executive Order on International Reference Pricing for Medicare Drugs (September 29, 2020)
- Ropes & Gray Honored With Three LMG 2020 Life Sciences Awards (September 24, 2020)
- In Law360, IP Litigators Examine Bill Curtailing Patent Troll Lawsuits at ITC (September 17, 2020)
- In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order (September 15, 2020)
- In Law360, LSRC Attorneys Examine HHS Announcement Barring FDA from Requiring Premarket Review for Laboratory-Developed Tests (September 2, 2020)
- In IP Litigator, Attorneys Examine U.S. Supreme Court Copyright and Trademark Cases (August 12, 2020)
- In Law360, Health Care Attorneys Examine Drug Pricing Reforms and Value-Based Pricing (August 3, 2020)
- In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements (July 10, 2020)
- Ropes & Gray Successfully Defends TCL and Roku in High-Profile Lawsuit Alleging Infringement of TCL Roku Smart TVs (June 26, 2020)
- In Law360, Attorneys Analyze Expanded U.S. Government Scrutiny of Research Compliance (June 26, 2020)
- In CNBC, Megan Bisk Explores Employer Liability from COVID-19 Workplace Lawsuits (June 22, 2020)
- In Bloomberg Law, Scott McKeown Examines Collateral Agreements Under Patent Law (June 17, 2020)
- Ropes & Gray Wins Federal Circuit Victory for Sioux Steel Company (June 16, 2020)
- In Science Magazine, Valerie Bonham Addresses NIH Challenges to Distribute COVID-19 Pandemic Research Funds (June 4, 2020)
- In Bloomberg Law, IP Attorneys Examine Bringing Trademark Law into the Dot-Com Age (June 4, 2020)
- Life Sciences Compliance Attorneys Examine CARES Act OTC Drug Framework Overhaul (June 2, 2020)
- In Bloomberg Law, Valerie Bonham Examines University Research Data Cybersecurity Risks (May 21, 2020)
- In Law360, Ed McNicholas and Kelsey McIntosh Analyze COVID-19 Consumer Data Protection Act (May 18, 2020)
- In Law360, IP Litigators Examine Federal Circuit Ruling Addressing Color Trade Dress Distinctiveness (May 12, 2020)
- In Bloomberg Law, Peter Brody Analyzes Complexities of SCOTUS Ruling on Georgia Copyright Doctrine (May 5, 2020)
- In Bloomberg Law, Marta Belcher Examines SCOTUS Ruling on States’ Copyright Doctrine (April 29, 2020)
- In MedTech Dive, Kellie Combs Examines FDA Guidance on Digital Health Devices for Treating Psychiatric Disorders (April 28, 2020)
- In Law360, Health Care Attorneys Analyze How to Determine Eligibility for U.S. Health and Human Services COVID-19 Emergency Funds (April 27, 2020)
- In Law360, Health Care Attorneys Examine COVID-19 Actions on Health Workers Staffing Shortage (April 15, 2020)
- IP Litigators Address How PREP Act May Fight Coronavirus-Related Patent Infringement Claims (April 10, 2020)
- In Bloomberg News, Matt Rizzolo Examines COVID-19 IP Rights for New Tests and Treatments (April 10, 2020)
- IP Litigators Address Challenges in Quantifying 5G Benefits and SEP Value (April 10, 2020)
- In Law360, FDA Regulatory Attorneys Examine How COVID-19 May Spur Passage of Lab Test Reform Legislation (April 8, 2020)
- In Forbes, Keith Higgins Analyzes SEC Safe Harbor Proposal for Cryptocurrencies (April 3, 2020)
- IP Litigators Address Potential for COVID-19 U.S. Government-Authorized Patent Infringement (April 3, 2020)
- In Bloomberg Law, Tom Bulleit Discusses COVID-19 Federal Health Regulation Changes (April 1, 2020)
- In Law360, Tom Bulleit Addresses Impact of COVID-19 Relief Bill on Drug Pricing Legislation (March 30, 2020)
- IP Litigator Matt Rizzolo Discusses Federal Circuit Ruling on PTAB Appointments (March 25, 2020)
- In Pink Sheet Articles, Life Sciences Attorneys Examine New FDA Provisions for Biosimilars (March 25, 2020)
- In Chemical & Engineering News, Valerie Bonham Examines Foreign Influence in Federal Research (March 24, 2020)
- Greg Levine Navigates Coronavirus Lab Test Developer Through Novel FDA Process (March 18, 2020)
- In The Chicago Tribune, Deborah Gersh Addresses Privacy Rules and Coronavirus Patient Identification (March 18, 2020)
- Federal Circuit Affirms IPR Win for Multi Packaging Solutions (March 17, 2020)
- In AHLA Connections Magazine, Valerie Bonham and Mark Barnes Examine Foreign Influence in Federally-Funded Research (March 11, 2020)
- In Law360, IP Litigators Examine Patent Damages for Willful Blindness (March 3, 2020)
- In Report on Medicare Compliance, Valerie Bonham Discusses Increased Scrutiny in Foreign Research Funding (March 3, 2020)
- In Forbes, Keith Higgins Addresses SEC Proposed Changes to Accredited Investor Designation (January 22, 2020)
- In Law360, Tom Bulleit and Scott Falin Recap 2019 Drug Pricing Initiatives and Look at 2020 (January 15, 2020)
- IP Litigators Examine Patent Legislation to Watch in 2020 (January 6, 2020)
- In Bloomberg Law, Health Care Attorney Addresses Delay in Harmonizing Human Research Rules (December 16, 2019)
- In The New York Times, Douglas Hallward-Driemeier Examines Hospital Groups Lawsuit to Block Price-Transparency Rule (December 6, 2019)
- In Reuters, IP Litigator Examines How Congressional Legislation Can Fix PTAB’s Appointments Clause (December 3, 2019)
- In Healthcare Risk Management, Health Care Partner Addresses Proposed “Value-Based” Changes to Stark and Anti-kickback Regulations (November 25, 2019)
- In Report on Research Compliance, Valerie Bonham Addresses Foreign Influence in Federal Grant Funding (October 17, 2019)
- In MedTech Dive, Greg Levine Addresses FDA Guidance on Regulating Clinical Decision Support Software (October 2, 2019)
- In Law360, IP Litigator Examines PTAB Estoppel Provision Splits in District Courts (September 5, 2019)
- Cross-Practice Attorneys Examine What Self-Disclosure Guidance Means for Federal Research Awardees (August 8, 2019)
- Health Care Partner Discusses Hospital Price Transparency Proposal (August 6, 2019)
- IP Litigator Examines Federal Circuit Ruling on Constitutionality of Patents Issued Before the America Invents Act (August 1, 2019)
- In Bloomberg Law, Health Care Partner Discusses Legal Challenges Facing Trump Administration’s International Drug Pricing Plan (July 15, 2019)
- IP Litigator Examines Mid-Year Patent Cases and U.S. Congress Patent Bill in Law360 and Bloomberg Law (July 10, 2019)
- In Law360, Health Care Attorneys Examine New CMS Bundled Payments Program (June 4, 2019)
- In Law360, Cross-Practice Team Examines Federal Circuit Decision in International Trade Dispute on False Advertising Claims (May 15, 2019)
- In Bloomberg Law, Health Care Partner Examines Final Rule on Drugmaker TV Ad Price Disclosures (May 14, 2019)
- In Law360, Life Sciences Attorneys Examine FDA Draft Guidance on Medical Device Inspections (May 13, 2019)
- IP Litigator Examines Federal Circuit Ruling in Trade Fight Over False Advertising Claims (May 3, 2019)
- IP Attorneys Author IP Litigator Article on U.S. Supreme Court Decision on “On Sale” Bar in Drug Patent Case (April 23, 2019)
- Asset Management Partner Nathan Briggs Quoted in Reuters on SEC Regulatory Proposal for Closed-End Funds (April 18, 2019)
- Reg BI Establishes Higher Standards for Broker-Dealers, Asset Management Counsel David Tittsworth States in Pensions & Investments (April 16, 2019)
- Law360 Quotes Asset Management Partner Mark Nuccio on OMB Memo Regarding White House Regulatory Reviews (April 15, 2019)
- In Pink Sheet, Life Sciences Partner Discusses Drug Pre-Approval Promotion (March 28, 2019)
- In Law360, IP Litigator Examines PTAB Motion to Amend Pilot Program (March 20, 2019)
- IP Litigator Discussed the PTAB’s New Amendment Pilot in PLI Webinar (March 18, 2019)
- IP Litigator Examines PTO’s New Precedent for Amending Patent Claims (March 13, 2019)
- In Bloomberg Law, Health Care Partner Addresses Pay-for-Delay Drug Deals (March 13, 2019)
- In Medical Marketing & Media, Attorneys Discuss Drug Pricing Proposals Before Congress (March 5, 2019)
- In Law360, Health Care Attorneys Look at HHS Health Technology Policy Rules (February 25, 2019)
- In Law360, Health Care Attorneys Examine Broader HHS Vision to Innovate Care Models (February 22, 2019)
- In Bloomberg Law, IP Litigator Discusses U.S. Supreme Court AIA Case (February 15, 2019)
- Ropes & Gray Attorneys Discuss the Government Shutdown’s Impact on the Asset Management Industry (February 4, 2019)
- Health Care Partner Discusses HHS Secretary’s First Year in Office (January 31, 2018)
- In Law360, IP Litigators Highlight Recent ITC-Related Federal Circuit Appeal (January 30, 2018)
- Asset Management Counsel David Tittsworth Discusses State-By-State Fiduciary Approach in IFLR (January 26, 2019)
- IP Litigator Quoted on U.S. Supreme Court Drug Patent Case Decision (January 24, 2018)
- In Law360, Cross-Practice Team Analyzes What is New in Federal and State Drug Pricing Initiatives (January 15, 2019)
- IP Litigator Examines New USPTO Patent Eligibility Guidance (January 8, 2019)
- In Law360, IP Litigator Addresses Government Shutdown Impact on USPTO (January 4, 2019)
- In Compliance Reporter, Management Counsel David Tittsworth Discusses Rep. Maxine Waters’ Nomination to Chair the House Financial Services Committee (December 11, 2018)
- In Inside Health Policy, Health Care Partner Discusses Expected Rule on PBM Drug Rebates and Safe Harbors (December 11, 2018)
- In Law360, Life Sciences Attorneys Address Proposed FDA Drug Software Rules (December 11, 2018)
- Health Care Attorneys Author Law360 Article on CMS Final Medicare Rules for Outpatient Payment Cost-Cutting (November 30, 2018)
- In The New York Times, IP Litigator Addresses the Use of Trademark Law in Motorcycle Club Racketeering Trial (November 27, 2018) javascript:void(0);
- In FundFire Investment Management Counsel David Tittsworth Discusses House Committee on Financial Services (November 21, 2018)
- Investment Management Counsel David Tittsworth Discusses the Midterm Election Results in Relation to Asset Management Priorities in Compliance Reporter (November 13, 2018)
- IP Litigators Examine How Next U.S. Congress Might Impact Patent Law (November 7, 2018)
- In Bloomberg Law, Health Care Partner Discusses Data Integrity in Shift to Value-Based Health Care Reimbursement (October 30, 2018)
- Health Care Co-Chair Discusses HIPAA Audits Focused on Enforcement (October 30, 2018)
- In Law360, Washington, D.C. Partners Analyze CMS’ Drug Price Disclosure Proposal (October 26, 2018)
- In FundFire Investment Management Counsel David Tittsworth Discusses SEC Tech Focus to Modernization (October 17, 2018)
- Bloomberg Law Publishes Article by Investment Management Counsel David Tittsworth Discussing SEC Staff Guidance (October 15, 2018)
- In Life Sciences IP Review Article, IP Litigators Address ITC as Potentially Powerful Forum for Biologics Patent Owners (October 15, 2018)
- Investment Management Counsel David Tittsworth Discusses Senate Action on Tax Reform in Compliance Reporter (October 5, 2018)
- Investment Management Counsel David Tittsworth Discusses the SEC’s Consolidated Audit Trail and the ICI’s “2018 Evolution Revolution” in ACA Insight (September 18, 2018)
- IP Litigator Examines Revised Procedures at the PTAB in The National Law Journal and Law360 (September 25, 2018)
- In Bloomberg Law, Health Care Attorneys Analyze Proposed Medicare Shared Savings Program Overhaul (September 12, 2018)
- The Wall Street Journal Quotes Investment Management Counsel David Tittsworth (September 5, 2018)
- BoardIQ Quotes Investment Management Counsel David Tittsworth on Derivatives Rule Re-Proposal (August 28, 2018)
- Investment Management Counsel David Tittsworth Quoted in ACA Insight on SEC Transparency Efforts (August 27, 2018)
- Investment Management Counsel David Tittsworth Discusses the SEC’s Best Interest Proposals Ahead of the Comment Period’s Close in Ignites and Fund Action (August 27, 2018)
- In Law360, Investment Management Counsel David Tittsworth Provides an Update on the SEC’s Evolving Asset Management Agenda (August 23, 2018)
- Wolters Kluwer Publishes Two Articles Co-Authored by Ropes & Gray Asset Management Attorneys (August 23, 2018)
- In Pensions & Investments Investment Management Counsel Weighs in on SCOTUS and SEC Nominees (August 23, 2018)
- PTAB Chair Examines Revisions to America Invents Act Guidelines (August 15, 2018)
- IP Litigator Examines Federal Circuit Ruling on Legal Fees and Statutory Interpretation in Bloomberg Law and Law360 (July 31, 2018)
- Health Care Partner Addresses FDA Bid to Lower Drug Prices in The Washington Post (July 19, 2018)
- In Pensions & Investments, Investment Management Counsel Discusses SCOTUS Nominee’s Challenges to Precedent on Deference to Regulators (July 17, 2018)
- IP Litigation Counsel Address U.S. Supreme Court Decision on Overseas Patent Damages (June 27, 2018)
- In Law360, Attorneys Examine FDA Final Guidance on Payor Communications and Communications Consistent with Labeling (June 27, 2018)
- Investment Management Counsel Quoted in HFMWeek on Potential Return of SEC Derivatives Rule (June 21, 2018)
- In Medical Marketing & Media, Life Sciences Partner Addresses Healthcare Marketing Changes Under Trump Administration (May 29, 2018)
- In Law360, Life Sciences Attorneys Examine Lessons From FDA Draft Guidance on Multifunctional Devices (May 23, 2018)
- Health Care Partner Analyzes President Trump’s Drug Pricing Speech (May 15, 2018)
- IP Litigator Addresses PTAB Claim Construction Change (May 14, 2018)
- In Law360, IP Litigator Writes About Possible Future “Patent Takings” Claims After U.S. Supreme Court’s Oil States Case (May 4, 2018)
- IP Litigators Examine Two U.S. Supreme Court Patent Case Decisions (April 26, 2018)
- IP Litigator Examines US Supreme Court’s Oral Arguments in Foreign Patent Damages Case (April 18, 2018)
- In Bloomberg Law, IP Litigator Addresses Potential Procedural Changes to District Court Patent Eligibility Challenges (April 12, 2018)
- IP Litigators Address Key PTAB Issues in Law.com (April 2, 2018)
- Boston Health Care Partner Quoted in Report on Research Compliance Article (March 21, 2018)
- In Bloomberg Law, PTAB Chair Examines Post-Grant Review Proceedings in Drug Patent Litigation (March 20, 2018)
- Investment Management Counsel David Tittsworth Quoted In FundFire On Deregulation Legislation (March 14, 2018)
- PTAB Chair Quoted in Intellectual Asset Management on Sovereign Immunity Decision (March 2, 2018)
- In Law360, IP Litigator Addresses Sovereign Immunity (February 26, 2018)
- In Law360, IP Litigator Addresses Federal Circuit Ruling on Patent Eligibility (February 15, 2018)
- Health Care Attorneys Author Law360 Article on DOJ Guidance Limits in Civil Enforcement Matters (February 12, 2018)
- In Investment Advisor/Think Advisor, Investment Management Counsel David Tittsworth Addresses Complications for the SEC’s Fiduciary Rule (February 1, 2018)
- In Bloomberg Big Law Business, IP Litigator Examines TC Heartland Patent Venue Decision (January 31, 2018)
- In Law360, IP Litigator Addresses U.S. Supreme Court Case on Overseas Patent Infringement Damages (January 23, 2018)
- In Law360, Washington Health Care Partner Addresses Patient Assistance Program Lawsuit (January 12, 2018)
- PTAB Chair Addresses Full Federal Circuit IPR One-Year Time-Bar Decision (January 10, 2018)
- In Corporate Counsel, PTAB Chair Addresses Top 2018 IP Concerns for In-House Counsel (January 8, 2018)
- Intellectual Property Litigator Quoted in Law.com on State Sovereign Immunity (January 4, 2018)
- In Law360, IP Litigators Examine 2018 Patent Litigation Trends to Watch (January 3, 2018)
- Intellectual Property Litigators Quoted in Reuters, Bloomberg BNA and Law360 on State Sovereign Immunity (December 22, 2017)
- In Law360, Life Sciences and Corporate Team Examines FDA Move to Limit Digital Software Regulations (December 22, 2017)
- In CBS MoneyWatch, Healthcare Partner Quoted on Navigating Obamacare Open Enrollment (December 13, 2017)
- Washington Health Care Partner Authors Ninth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (December 7, 2017)
- Supreme Court Searches for Fourth Amendment Line for the Digital Economy (December 6, 2017)
- Rosenstein Announces Permanent FCPA “Pilot Program,” Presumption of Declination When Self-Reporting, but Difficult Choices Remain (December 5)
- IRS Notice Provides Guidance on Use of Donor Advised Funds for Pledges and Charity Events (December 5, 2017)
- New Burma Act Would Hinder US Investment In Myanmar (December 4, 2017)
- Ropes & Gray Names Alexandre Rene as Head of its Washington, D.C. Office (November 29, 2017)
- Ropes & Gray Partners with the CFA Society For a Discussion on What to Expect From the New SEC (November 28, 2017)
- New Cuba Sanctions Signal Increased Commercial Challenges (November 10, 2017)
- SEC Issues No-Action Letters to Ease U.S. and MiFID II Compliance; EC Issues Guidance on MiFID II Advisers’ Receipt of Research from Non-EU Brokers(November 9, 2017)
- Ropes & Gray Investment Management Counsel Comments on the SEC’s Data breach in ACA Insight (November 7, 2017)
- At ACA's 2017 Fall Compliance Conference, Investment Management Counsel Discusses the Impact of Politics on Investment Adviser Industry (November 7, 2017)
- Trending Video: FTC’s Merger Remedies Study (November 3, 2017)
- Q&A: What to Expect from the “New” SEC (November 1, 2017)
- In ACA Insight, Ropes & Gray Investment Management Counsel Discusses Key Issues for the SEC and the Commissioner Nominees (October 31, 2017)
- Investment Management Counsel Provides Opening Address at the NRS Fall 2017 Compliance Conference (October 31, 2017)
- In CBS MoneyWatch, Health Care Partner Discusses Navigating Obamacare Open Enrollment (October 30, 2017)
- Investment Management Partner Widely Quoted in Asset Management Media on Cybersecurity at the SEC (October 24, 2017)
- Cryptocurrency Update: CFTC Reaffirms Jurisdiction Over Certain Virtual Currency Transactions (October 19, 2017)
- Health Care Partner Authors Eighth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (October 19, 2017)
- SEC Issues Guidance on Non-GAAP Financial Measures in Business Combination Projections (October 18, 2017)
- SEC Proposes Amendments to Modernize and Simplify Regulation S-K (October 16, 2017)
- Health Care Attorneys Author Law360 Article on Future of Value-Based Health Care (October 5, 2017)
- Health Care Partner Quoted in Law360 on Latest Obamacare Repeal Failure (September 26, 2017)
- Health Care Partner Authors Seventh Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (September 22, 2017)
- Health Care Attorneys Author Law360 Article on Health Care Providers Becoming Payors (September 21, 2017)
- Bloomberg BNA, InvestmentNews and Fund Action Quote Investment Management Counsel Investment Management Counsel on SEC Commissioner Nominees and Leadership (September 19, 2017)
- Investment management counsel quoted in InvestmentNews, Fund Directions, Ignites and Law360 on business continuity planning (September 18, 2017)
- OIG's Warranty Safe Harbor Opinion And Value-Based Care (September 15, 2017)
- Health Care Partner Authors Sixth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (August 10, 2017)
- Health Care Partner Quoted in Law360 on Next Steps After Obamacare Repeal Failure (July 31, 2017)
- Intellectual Property Litigator Addresses Impact of U.S. Senate’s STRONGER Patents Act in Inside Counsel (July 25, 2017)
- Health Care Partners Fifth Column on “Repeal and Replace” for Series in Bloomberg BNA’s Health Law Reporter Addresses Legislative Challenge of Building Bipartisan Bill to Repair Obamacare (July 21, 2017)
- Health Care Partner Quoted in Law360 on Expectations for Obamacare Repeal in U.S. Senate (July 11, 2017)
- Tax & Benefits Attorney Discusses the DOL’s Request for Information on the Fiduciary Rule (July 11, 2017)
- Health Care Partner Addresses U.S. Health Care Reform on CBS Radio (June 29, 2017)
- Health Care Partner Quoted in Modern Healthcare and Bloomberg BNA on U.S. Senate’s Health Care Draft Bill (June 23, 2017)
- Searching for Goldilocks: Five Takeaways From the Senate's Health-Care Reform Porridge-Making (June 22, 2017)
- Investment Management Counsel Provides Insights on the Financial Choice Act in WSJ Pro PE, InvestmentNews, Compliance Week, and FundFire (June 19, 2017)
- In InvestmentNews’ “Fiduciary Focus” Podcast, Ropes & Gray Tax & Benefits Attorney Discusses the Next Phase of The Fiduciary Rule’s Rollout (June 13, 2017)
- In The Hedge Fund Law Report, Investment Management Counsel Provides Insights on The Financial CHOICE Act of 2017 (June 5, 2017)
- Health Care Partner Quoted in Law360 on Republican Legislation to Repeal Obamacare (May 30, 2017)
- Health Care Partner Quoted in CBS MoneyWatch on Congressional Budget Office Analysis of Republican Health Care Bill (May 26, 2017)
- In ACA Insight, Investment Management Counsel Discusses Priorities for New SEC Chairman Jay Clayton (May 12, 2017)
- Health Care Partner Quoted in National Law Journal on Guidance for Legal Counsel After Passage of AHCA (May 8, 2017)
- Investment Management Counsel Authors Article Examining President Trump’s Executive Orders Relating to the Financial Services Industry (May 5, 2017)
- Buyouts Quotes Ropes & Gray tax partner on President Trump's Tax-Reform Proposal (May 5, 2017)
- “Reports of the AHCA's Revival: Will Giving the States Obamacare Waivers Thread the Needle?” Bloomberg BNA's Health Law Report (April 27, 2017)
- Health Care Partner Examines MacArthur Amendment to the American Health Care Act in Bloomberg BNA (April 27, 2017)
- “Failure to Launch the American Health Care Act: Portents for the Future of Health Care Reform?” Bloomberg BNA's Health Law Report (April 6, 2017)
- Law360 quotes health care partner Deb Gersh on Trump's HHS Fast To Grant Industry Wishes (March 20, 2017)
- Law360 quotes government enforcement partner Nick Berg on Obama-Era rules (March 10, 2017)
- Bloomberg BNA Health Care Daily Report Quotes Health Care Partner Thomas Bulleit on the GOP Health Plan (March 8, 2017)
- Investment Management Counsel Quoted Extensively on Proposed Fiduciary Rule Delay (March 6, 2017)
- “The Price of TrumpCare: Five Takeaways From the HHS Secretary and Other Republican Proposals,” Bloomberg BNA's Health Law Report (February 23, 2017)
- In National Law Journal Health Care Partner Discusses ACA Repeal (February 15, 2017)
- In Hedge Fund Legal & Compliance Digest Ropes & Gray Attorneys Discuss the SEC Under President Trump (February 9, 2017)
- Bloomberberg BNA Health Law Reporter Quotes Health Care Partner Mark Barnes on Trump Travel Ban, Bloomberg BNA's Health Care Daily Report (February 2, 2017)
- “Trump's '2-for-1' regulation order seems straightforward, but it isn't,” The Business Journals (January 31, 2017)
- “Trump order targeting business rules leaves key regulations untouched,” Reuters (January 30, 2017)
- “Trump’s latest executive order targets and caps new regulations,” FierceHealthcare (January 30, 2017)
- Bloomberg BNA Health Law Reporter Quotes Health Care Partner Tom Bulleit on Obamacare Executive Order Bloomberg BNA's Health Care Daily Report
(January 26, 2017) - Investment Management Counsel: “The World According to Trump” (January 19, 2017)
- “White House Finalizes Scaled Back Research Regs,” Health Care Daily Report (January 18, 2017)
- Health Care and FDA Changes Expected Under Trump Administration (January 11, 2017)
- “The New U.S. Department of Health and Human Services: Tom Price and Value-Based Health Care,” JD Supra Business Advisor (January 6, 2017)
- “The New FDA: Product Development, Pricing and Beyond,” JD Supra Business Advisor (January 6, 2017)
- “Life Sciences Legislation and Regulation to Watch In 2017,” Law360 (January 2, 2017)
- “GOP Repeal-And-Delay Plans Spell Uncertainty For Insurers,”HealthcareDIVE (December 14, 2016)
- “Tax & Benefits Counsel Discusses Trump’s Potential Impact on Charitable Giving in Bloomberg BNA’s Daily Tax Report,” (December 14, 2016)
- “Trump Administration Could End Need for ACA Appeal, House Republicans Say,” Bloomberg BNA Health Law Reporter (December 1, 2016)
- “In Reuters, Investment Management Partner Discusses the Future of the Volcker Rule Under the Trump Administration (November 30, 2016)
- “In Ignites and Fund Board Views, Investment Management Counsel Discusses the Future of FSOC and the Derivatives Rule Under a New President and New SEC Chair”(November 30, 2016)
- “Health Care Partner Quoted in Life Sciences Law & Industry News Article on the Obama Administration Trying to Release a Major Revision to the Common Rule Before Inauguration Day,” Bloomberg BNA Life Sciences & Industry Report (November 18, 2016)
- “Obamacare Cases in Limbo Following Republican Wins in White House, Congress,” Bloomberg BNA Health Law Reporter (November 17, 2016)
- “Life Sciences Partner Quoted in Bloomberg BNA’s Health Care Daily Report on Drug Industry Facing Less Scrutiny Under President Trump and the New U.S. Congress,” (November 15, 2016)
- “Private Client Group Partner Quoted in The New York Times on Tax Policy under President-elect Trump,” (November 14, 2016)
- “Republicans Face Divisions over ObamaCare Repeal,” The Hill (November 13, 2016)
- “Experts Struggle to Predict How Trump Will Use Sanctions,”The Wall Street Journal (November 11, 2016)
- “How GCs Should Prepare for Trump's ACA Repeal,” Corporate Counsel (November 11, 2016)
- “Trumping Obamacare: Some Likely Effects of the Election on Health Care,” (November 10, 2016)
- “In Health Care Daily Report, Health Care and Life Sciences Partners Discuss the Drug Pricing Under Trump,” Health Care Daily Report (November 10, 2016)
- “Iran-Deal Sanctions Relief Could Be Overturned With ‘Stroke of a Pen,” Wall Street Journal (November 9, 2016)
- “Bye-bye Dodd-Frank? What Donald Trump's win means for the banking red tape,” City A.M. (November 9, 2016)
- “In Law360, Health Care Partner Reacts to Trump's Election To The White House,” Law360 (November 9, 2016)
- “Trump's Victory Will Reshape Financial Rules, Supreme Court,”The National Law Journal (November 9, 2016)